Tardive Dyskinesia Treatment Global Market Report 2025

Description

Tardive dyskinesia treatment involves medical management and therapeutic approaches designed to reduce or control the involuntary, repetitive movements that result from long-term use of dopamine receptor-blocking agents, particularly antipsychotic medications.

The primary treatment types include medications, botulinum toxin injections, deep brain stimulation, and other therapeutic options. Medications are drugs specifically prescribed to manage and lessen the involuntary movements associated with prolonged antipsychotic use, with commonly used options including valbenazine, amantadine, tetrabenazine, clonazepam, and others. These treatments can be administered through different routes such as oral administration, injections, or transdermal patches. Distribution takes place through hospital pharmacies, retail pharmacies, and other channels, serving various end users including hospitals, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The tardive dyskinesia treatment market research report is one of a series of new reports from The Business Research Company that provides tardive dyskinesia treatment market statistics, including tardive dyskinesia treatment industry global market size, regional shares, competitors with a tardive dyskinesia treatment market share, detailed tardive dyskinesia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tardive dyskinesia treatment industry. This tardive dyskinesia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tardive dyskinesia treatment market size has grown strongly in recent years. It will grow from $2.40 billion in 2024 to $2.61 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the rising use of antipsychotic medications, increasing awareness of drug-induced movement disorders, a higher incidence of schizophrenia and bipolar disorders, greater off-label use of antipsychotics, and the expanding geriatric population using psychotropic drugs.

The tardive dyskinesia treatment market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to the increasing demand for safer antipsychotic therapies, rising awareness through advocacy and education initiatives, a stronger focus on personalized mental health treatments, higher healthcare spending on neurological and psychiatric disorders, and the growing number of psychiatric patients requiring long-term therapy. Key trends anticipated during this period include the development of neuroprotective strategies, advancement of dual-action therapies, incorporation of real-world evidence (RWE) in drug evaluation, integration of digital biomarkers, and innovations in non-dopaminergic therapeutic approaches.

The increasing prevalence of psychiatric disorders is expected to drive the growth of the tardive dyskinesia treatment market in the coming years. Psychiatric disorders encompass a wide range of mental health conditions that affect mood, thinking, behavior, and overall functioning, often requiring medical diagnosis and treatment. Their rising prevalence is linked to growing stress and lifestyle pressures caused by heavy workloads, social isolation, and limited time for self-care. Tardive dyskinesia treatments help manage involuntary movement symptoms, thereby improving treatment outcomes and quality of life for patients with psychiatric disorders who require long-term antipsychotic medications. For example, in March 2024, the House of Commons Library, a UK-based research and information service, reported that the proportion of 17- to 19-year-olds with a probable mental disorder rose from 17% in 2021 to 26% in 2022. As a result, the increasing prevalence of psychiatric disorders is fueling demand for tardive dyskinesia treatments.

Companies in the tardive dyskinesia treatment market are focusing on innovative drug formulations, such as sprinkle capsules, to improve adherence among patients with swallowing difficulties. Sprinkle capsule formulations are designed to be opened and mixed with soft food, making them easier to take for patients with dysphagia or difficulty swallowing whole capsules. For instance, in July 2024, Neurocrine Biosciences Inc., a US-based biotechnology company, launched Ingrezza sprinkle (valbenazine) capsules, the leading prescribed vesicular monoamine transporter 2 (VMAT2) inhibitor for the treatment of adults with tardive dyskinesia and chorea associated with Huntington's disease. This VMAT2 inhibitor helps regulate dopamine levels in the brain to manage involuntary movements and is available as a once-daily oral capsule, including a sprinkle formulation for easier administration in patients with swallowing challenges.

In April 2025, Johnson & Johnson, a US-based pharmaceutical company, acquired Intra-Cellular Therapies for an undisclosed amount. This acquisition allows Johnson & Johnson to strengthen its neuroscience leadership and expand its position in the growing mental health treatment market. Intra-Cellular Therapies Inc. is a US-based pharmaceutical company specializing in treatments for tardive dyskinesia.

Major players in the tardive dyskinesia treatment market are AbbVie Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Jazz Pharmaceuticals plc, Kyowa Kirin Co Ltd., H. Lundbeck A/S, Zydus Lifesciences Limited, Neurocrine Biosciences Inc., Luye Pharma Group Ltd., Acadia Pharmaceuticals Inc., Upsher-Smith Laboratories LLC, SteriMax Inc., Adamas Pharmaceuticals Inc., ChemWerth Inc, Sunovion Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Synnat Pharma Pvt. Ltd, LGM Pharma LLC, and SOM Biotech S.A.

North America was the largest region in the tardive dyskinesia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tardive dyskinesia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tardive dyskinesia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tardive dyskinesia treatment market includes revenues earned by entities through botulinum toxin injection services, deep brain stimulation procedures, and diagnostic and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tardive Dyskinesia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tardive dyskinesia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tardive dyskinesia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tardive dyskinesia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Type: Medications; Botulinum Toxin Injections; Deep Brain Stimulation; Other Treatment Types
2) By Drug: Valbenazine; Amantadine; Tetrabenazine; Clonazepam; Other Drugs
3) By Route Of Administration: Oral Administration; Injection; Transdermal Patches
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Medications: Antipsychotic Medications; Benzodiazepines; Dopamine-Depleting Agents; Anticholinergic Agents
2) By Botulinum Toxin Injections: Facial Muscle Injections; Neck Muscle Injections; Limb Muscle Injections; Customized Injection Protocols
3) By Deep Brain Stimulation: Subthalamic Nucleus Stimulation; Globus Pallidus Interna Stimulation; Thalamic Stimulation; Multi-Target Stimulation
4) By Other Treatment Types: Supportive Therapies; Cognitive Behavioral Therapy; Physical Rehabilitation; Emerging Experimental Treatments
Companies Mentioned: AbbVie Inc.; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Limited; Otsuka Pharmaceutical Co. Ltd.; Jazz Pharmaceuticals plc; Kyowa Kirin Co Ltd.; H. Lundbeck A/S; Zydus Lifesciences Limited; Neurocrine Biosciences Inc.; Luye Pharma Group Ltd.; Acadia Pharmaceuticals Inc.; Upsher-Smith Laboratories LLC; SteriMax Inc; Adamas Pharmaceuticals Inc.; ChemWerth Inc; Sunovion Pharmaceuticals Inc.; Mitsubishi Tanabe Pharma Corporation; Synnat Pharma Pvt. Ltd; LGM Pharma LLC; SOM Biotech S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37902

1. Executive Summary

2. Tardive Dyskinesia Treatment Market Characteristics

3. Tardive Dyskinesia Treatment Market Trends And Strategies

4. Tardive Dyskinesia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tardive Dyskinesia Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Tardive Dyskinesia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tardive Dyskinesia Treatment Market Growth Rate Analysis
5.4. Global Tardive Dyskinesia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tardive Dyskinesia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tardive Dyskinesia Treatment Total Addressable Market (TAM)

6. Tardive Dyskinesia Treatment Market Segmentation

6.1. Global Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Botulinum Toxin Injections
Deep Brain Stimulation
Other Treatment Types
6.2. Global Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Valbenazine
Amantadine
Tetrabenazine
Clonazepam
Other Drugs
6.3. Global Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Administration
Injection
Transdermal Patches
6.4. Global Tardive Dyskinesia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels
6.5. Global Tardive Dyskinesia Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End-Users
6.6. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antipsychotic Medications
Benzodiazepines
Dopamine-Depleting Agents
Anticholinergic Agents
6.7. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Botulinum Toxin Injections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Facial Muscle Injections
Neck Muscle Injections
Limb Muscle Injections
Customized Injection Protocols
6.8. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Deep Brain Stimulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subthalamic Nucleus Stimulation
Globus Pallidus Interna Stimulation
Thalamic Stimulation
Multi-Target Stimulation
6.9. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Supportive Therapies
Cognitive Behavioral Therapy
Physical Rehabilitation
Emerging Experimental Treatments

7. Tardive Dyskinesia Treatment Market Regional And Country Analysis

7.1. Global Tardive Dyskinesia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Tardive Dyskinesia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tardive Dyskinesia Treatment Market

8.1. Asia-Pacific Tardive Dyskinesia Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tardive Dyskinesia Treatment Market

9.1. China Tardive Dyskinesia Treatment Market Overview
9.2. China Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tardive Dyskinesia Treatment Market

10.1. India Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tardive Dyskinesia Treatment Market

11.1. Japan Tardive Dyskinesia Treatment Market Overview
11.2. Japan Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tardive Dyskinesia Treatment Market

12.1. Australia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tardive Dyskinesia Treatment Market

13.1. Indonesia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tardive Dyskinesia Treatment Market

14.1. South Korea Tardive Dyskinesia Treatment Market Overview
14.2. South Korea Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tardive Dyskinesia Treatment Market

15.1. Western Europe Tardive Dyskinesia Treatment Market Overview
15.2. Western Europe Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tardive Dyskinesia Treatment Market

16.1. UK Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tardive Dyskinesia Treatment Market

17.1. Germany Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tardive Dyskinesia Treatment Market

18.1. France Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tardive Dyskinesia Treatment Market

19.1. Italy Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tardive Dyskinesia Treatment Market

20.1. Spain Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tardive Dyskinesia Treatment Market

21.1. Eastern Europe Tardive Dyskinesia Treatment Market Overview
21.2. Eastern Europe Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tardive Dyskinesia Treatment Market

22.1. Russia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tardive Dyskinesia Treatment Market

23.1. North America Tardive Dyskinesia Treatment Market Overview
23.2. North America Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tardive Dyskinesia Treatment Market

24.1. USA Tardive Dyskinesia Treatment Market Overview
24.2. USA Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tardive Dyskinesia Treatment Market

25.1. Canada Tardive Dyskinesia Treatment Market Overview
25.2. Canada Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tardive Dyskinesia Treatment Market

26.1. South America Tardive Dyskinesia Treatment Market Overview
26.2. South America Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tardive Dyskinesia Treatment Market

27.1. Brazil Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tardive Dyskinesia Treatment Market

28.1. Middle East Tardive Dyskinesia Treatment Market Overview
28.2. Middle East Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tardive Dyskinesia Treatment Market

29.1. Africa Tardive Dyskinesia Treatment Market Overview
29.2. Africa Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tardive Dyskinesia Treatment Market Competitive Landscape And Company Profiles

30.1. Tardive Dyskinesia Treatment Market Competitive Landscape
30.2. Tardive Dyskinesia Treatment Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Jazz Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

31. Tardive Dyskinesia Treatment Market Other Major And Innovative Companies

31.1. Kyowa Kirin Co Ltd.
31.2. H. Lundbeck A/S
31.3. Zydus Lifesciences Limited
31.4. Neurocrine Biosciences Inc.
31.5. Luye Pharma Group Ltd.
31.6. Acadia Pharmaceuticals Inc.
31.7. Upsher-Smith Laboratories LLC
31.8. SteriMax Inc
31.9. Adamas Pharmaceuticals Inc.
31.10. ChemWerth Inc
31.11. Sunovion Pharmaceuticals Inc.
31.12. Mitsubishi Tanabe Pharma Corporation
31.13. Synnat Pharma Pvt. Ltd
31.14. LGM Pharma LLC
31.15. SOM Biotech S.A.

32. Global Tardive Dyskinesia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tardive Dyskinesia Treatment Market

34. Recent Developments In The Tardive Dyskinesia Treatment Market

35. Tardive Dyskinesia Treatment Market High Potential Countries, Segments and Strategies

35.1 Tardive Dyskinesia Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Tardive Dyskinesia Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Tardive Dyskinesia Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer